Clopidogrel
Articles · Medicine Compliance Aid Stability · Lactation Safety Information · Published , updated
108979001
Articles
18th September 2020
Safety in Lactation: Drugs for thromboembolic disorders
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Oral anticoagulants The coumarin anticoagulants, warfarin… Abciximab Acenocoumarol Alteplase Apixaban Argatroban Aspirin Cardiovascular system disorders Clopidogrel Dabigatran etexilate Dalteparin Dipyridamole Edoxaban Enoxaparin Epoprostenol Eptifibatide Fondaparinux Heparin Phenindione Prasugrel Rivaroxaban Safety in Lactation Ticagrelor Tinzaparin Urokinase Warfarin
23rd January 2020
Chondroitin – what are its drug interactions?
There are two published case reports of increased INR in patients receiving warfarin who self-medicated with glucosamine-chondroitin supplements. INR was increased in a further three… Acenocoumarol Apixaban Chondroitin Clopidogrel Complementary and alternative therapies Dabigatran etexilate Dipyridamole Edoxaban Glucosamine sulfate + Chondroitin Q&A Rivaroxaban Warfarin
25th July 2019
Do proton pump inhibitors reduce the clinical efficacy of clopidogrel?
This updated Medicines Q&A evaluates the available evidence for an interaction between clopidogrel and proton pump inhibitors Summary Clopidogrel is converted into its active metabolite… Clopidogrel Esomeprazole Lansoprazole Omeprazole Pantoprazole Q&A RabeprazoleMedicine Compliance Aid Stability
Grepid · Beacon Pharmaceuticals
Beacon Pharmaceuticals
Grepid
Tablets 75mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
The tablets should be protected from light.
9th November 2015
generic · Consilient Health UK Ltd
Consilient Health UK Ltd
generic
Tablets 75mg
A2 · Amber 2 · No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Protect from light
Protect from moisture
There are anecdotal reports of clopidogrel hydrochloride tablets becoming brittle and breaking after storage in MCA. The tablets should be protected from light and moisture.
9th November 2015
Plavix · Sanofi
Sanofi
Plavix
Tablets 75mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
The tablets should be protected from light and moisture.
9th November 2015
Lactation Safety Information
Aspirin, Dipyridamole
No published evidence of safety
See also Note in summary
20th October 2016